Aardvark Therapeutics, Inc. Common Stock (AARD)

Aardvark Therapeutics, Inc. Common Stock (AARD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $104M; returns 1 day -64.8%, 1 week -63.2%, 1 year -87.2%.

Aardvark Therapeutics, Inc. (NASDAQ: AARD) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, founded in 2017. The company is focused on developing novel, small-molecule therapeutics that activate innate homeostatic pathways to alleviate hunger and treat metabolic diseases.

Groups AARD belongs to

• Clinical Stage Biopharma
• Biotechnology
• Metabolic Disorders
• Prader-Willi Syndrome
• Weight Management
• Rare Diseases
• Healthcare
• Biopharmaceutical
• Clinical Stage
• Pharmaceuticals
• GLP-1 Agonists

AARD financial model: income statement, cash flow and balance sheet